drugset / Trial / NCT01187043
Determination of the Lowest, Safe and Effective Dose of Proellex
RandomizedCrossoverSingle-blindTreatment
Summary
The purpose of this study is to determine the effects of five different doses of Proellex on menses, ovulation, liver function, and steady state exposure in women of reproductive age.
Timeline
- Start
- 2010-08
- Primary completion
- 2012-03
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Telapristone Acetate | Other / unclassified | 1 mg | Oral |
| Subject | Telapristone Acetate | Other / unclassified | 3 mg | Oral |
| Subject | Telapristone Acetate | Other / unclassified | 6 mg | Oral |
| Subject | Telapristone Acetate | Other / unclassified | 9 mg | Oral |
| Subject | Telapristone Acetate | Other / unclassified | 12 mg | Oral |